Saliva is effective in screening for CMV infection in newborns, says NIH-funded research
June 10th, 2011
Swabbing a newborn’s mouth for saliva can be used to quickly and effectively screen for cytomegalovirus (CMV) infection, a leading cause of hearing loss in children, says research in the June 2 issue of the New England Journal of Medicine.
Related posts:
- Medicare Card – Traditional ‘Heel Stick’ Test Is Not an Effective Screening Tool for CMV in Newborns A routine screening test for several metabolic and genetic disorders in newborns, the heel-stick procedure, is not effective in screening for cytomegalovirus (CMV)...
- Effort to define markers of human immune responses to infection and vaccination A new nationwide research initiative has been launched to define changes in the human immune system, using human and not animal studies, in response to infection or to vaccination. Six U. S.-based Human Immune Phenotyping Centers will receive a total of $100 million over five years to conduct this research....
- Medicare Expands List of Covered Preventive Services to Include HIV Screening Tests The Centers for Medicare & Medicaid Services (CMS) today announced its final decision to cover Human Immunodeficiency Virus (HIV) infection screening for Medicare beneficiaries who are at increased risk for the infection, including women who are pregnant and Medicare beneficiaries of any age who voluntarily request the service....
- Therapeutics for Rare and Neglected Diseases Program announces next round of drug development projects Researchers will begin drug development projects for rare and neglected diseases that include potential treatments for a musculoskeletal disorder, a cognitive dysfunction disorder, a virus that affects the central nervous system of newborns, a parasitic worm infection, a form of muscular dystrophy and a rare lung disease....
- Medicare Card: NIH-Supported Experimental Marburg Vaccine Prevents Disease Two Days after Infection An experimental vaccine developed to prevent outbreaks of Marburg hemorrhagic fever continues to show promise in monkeys as an emergency treatment for accidental exposures to the virus that causes the disease. There is no licensed treatment for Marburg infection, which has a high fatality rate....
- Medicare STAR METRICS, New Way to Measure the Impact of Federally Funded Research A new initiative promises to monitor the impact of federal science investments on employment, knowledge generation, and health outcomes. The initiative–Science and Technology for America’s Reinvestment: Measuring the Effect of Research on Innovation, Competitiveness and Science, or STAR METRICS–is a multi-agency venture led by the National Institutes of Health, the National Science Foundation (NSF), and […]...
- Funded study shows 20 percent reduction in lung cancer mortality with low-dose CT compared to chest X-ray Scientists have found a 20 percent reduction in deaths from lung cancer among current or former heavy smokers who were screened with low-dose helical computed tomography (CT) versus those screened by chest X-ray. The primary research results from the National Lung Screening Trial (NLST) were published online today in the New England Journal of Medicine. […]...
- Ultrathin flexible brain implant offers unique look at seizures in NIH-funded research Researchers funded by the National Institutes of Health have developed a flexible brain implant that could one day be used to treat epileptic seizures....
- Medicare Expands List of Covered Preventive Services to Include HIV Screening Tests The Centers for Medicare & Medicaid Services (CMS) today announced its final decision to cover Human Immunodeficiency Virus (HIV) infection screening for Medicare beneficiaries who are at increased risk for the infection, including women who are pregnant and Medicare beneficiaries of any age who voluntarily request the service. The decision is effective immediately....
- Panel Calls for Reducing Colorectal Cancer Deaths by Striking Down Barriers to Screening Colorectal cancer is the second leading cause of cancer-related deaths in the United States. Despite evidence and guidelines supporting the value of screening for this disease, rates of screening for colorectal cancer are consistently lower than those for other types of cancer, particularly breast and cervical. ...
- Funded study uses planning prompts to enhance vaccination rates We all have good intentions, but sometimes we need a nudge to turn those intentions into actions. According to a new study, encouraging people to write down the date and time when they plan to get their flu shot increased the number of people who were vaccinated. MedicareCard.com has been serving consumers for several years […]...
- Social Security Holds Disability Hearing Michael J. Astrue, Commissioner of Social Security, today hosted the agency’s fifth public hearing on Compassionate Allowances. Commissioner Astrue was joined by Philip Wang, M.D., Dr. P.H., National Institute of Mental Health, National Institutes of Health, and Social Security executives. They heard testimony from some of the nation's leading experts on schizophrenia about possible methods of identifying and implementing Compassionate Allowances for young adults with schizophrenia....
- NIH-funded study shows early brain effects of HIV in mouse model A new mouse model closely resembles how the human body reacts to early HIV infection and is shedding light on nerve cell damage related to the disease, according to researchers funded by the National Institutes of Health....
- Saw palmetto no more effective than placebo for urinary symptoms Saw palmetto, a widely used herbal dietary supplement, does not reduce urinary problems associated with prostate enlargement any better than a placebo, according to research funded by the National Institutes of Health. The study was published Sept. 28 in the Journal of the American Medical Association....
- NIH-Funded Study Finds Early HAART during TB Treatment Boosts Survival Rate in People Co-Infected with HIV and TB A clinical trial in Cambodia has found it possible to prolong the survival of untreated HIV-infected adults with very weak immune systems and newly diagnosed tuberculosis (TB) by starting anti-HIV therapy two weeks after beginning TB treatment, rather than waiting eight weeks, as has been standard. This finding by scientists co-funded by the National Institute […]...
Posted in Medicare Card Replacement | Tags: MEDICARE CARD REPLACEMENT